MBDB

Methylbenzodioxolylbutanamine
	Chemical structure
Clinical data
Other names	Methylbenzodioxolyl-butanamine; N-Methyl-1,3-benzodioxolylbutanamine; MBDB; 3,4-Methylenedioxy-N-methyl-butanphenamine; MDMB; 1,3-Benzodioxolyl-N-methylbutanamine; BDMB; 3,4-Methylenedioxy-N-methyl-α-ethylphenylethylamine; 3,4-Methylenedioxy-N-methyl-α-desmethyl-α-ethylamphetamine; Eden; Methyl-J
Drug class	Serotonin–norepinephrine releasing agent; Empathogen–entactogen
Legal status
Legal status	AU: S9 (Prohibited substance); DE: Anlage I (Authorized scientific use only); UK: Class A; US: Schedule I (Positional Isomer of MDEA);
Pharmacokinetic data
Duration of action	4–6 hours
Identifiers
	IUPAC name 1-(1,3-Benzodioxol-5-yl)-N-methylbutan-2-amine;
CAS Number	135795-90-3 ;
PubChem CID	124844;
ChemSpider	111153;
UNII	E8HMQ4F9JQ;
KEGG	C22786;
CompTox Dashboard (EPA)	DTXSID70894039 ;
Chemical and physical data
Formula	C12H17NO2
Molar mass	207.273 g·mol−1
3D model (JSmol)	Interactive image;
Melting point	156 °C (313 °F)
	SMILES CCC(CC1=CC2=C(C=C1)OCO2)NC;
	InChI InChI=1S/C12H17NO2/c1-3-10(13-2)6-9-4-5-11-12(7-9)15-8-14-11/h4-5,7,10,13H,3,6,8H2,1-2H3; Key:USWVWJSAJAEEHQ-UHFFFAOYSA-N;
	(verify)

MBDB, also known as N-methyl-1,3-benzodioxolylbutanamine or as 3,4-methylenedioxy-N-methyl-α-ethylphenylethylamine, is an entactogen of the phenethylamine, amphetamine, and phenylisobutylamine families related to MDMA.^[1]^[2]^[3]^[4] It is known by the street names "Eden" and "Methyl-J".^[4]

^ Oeri HE (May 2021). "Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy". J Psychopharmacol. 35 (5): 512–536. doi:10.1177/0269881120920420. PMC 8155739. PMID 32909493.
^ Aerts LA, Mallaret M, Rigter H (July 2000). "N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine (MBDB): its properties and possible risks". Addict Biol. 5 (3): 269–282. doi:10.1111/j.1369-1600.2000.tb00191.x. PMID 20575841.
^ Cite error: The named reference NicholsMarona-LewickaHuang1993 was invoked but never defined (see the help page).
^ ^a ^b "MBDB". Erowid Center.

[Oeri2021-1] Oeri HE (May 2021). "Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy". J Psychopharmacol. 35 (5): 512–536. doi:10.1177/0269881120920420. PMC 8155739. PMID 32909493.

[AertsMallaretRigter2000-2] Aerts LA, Mallaret M, Rigter H (July 2000). "N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine (MBDB): its properties and possible risks". Addict Biol. 5 (3): 269–282. doi:10.1111/j.1369-1600.2000.tb00191.x. PMID 20575841.

[NicholsMarona-LewickaHuang1993-3] Cite error: The named reference NicholsMarona-LewickaHuang1993 was invoked but never defined (see the help page).

[Erowid-MBDB-4] "MBDB". Erowid Center.

[1]

[2]

[3]

[4]